Fuel Progress
Dive into the collective wisdom, insights, and strategies from experts in pharma and biotech.
OVN Podcasts
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Kirk Shepard
Trust, Transparency & Timelines: Advancing Cancer Care
Ramin Farhood
Busting Silos: Building the Future of Oncology Drug Development
Featured Podcasts
Monty Pal
Asking the Impossible: How Bold Questions are Unlocking Diabetes Biggest Breakthroughs
Monty Pal
Translating Discovery: Shaping Tomorrow’s Prostate Cancer Therapies
Monty Pal
The Quest to Cure: Exploring the Latest Frontiers in Autoimmune Disease Treatment
Monty Pal
The Future of Cancer Surgery: Innovations, AI and Remote Robotics
Monty Pal
How Mentorship Sparks Innovation: A Conversation with Dr. Wesley Yip
Monty Pal
How Team Science Fuels Cancer Breakthroughs: A Conversation with Dr. Marcel van den Brink
Trending on OVN
01
Yuan Zhang, Xu Liu, Ying-Qin Li, Ling-Long Tang, Lei Chen, Jun Ma
A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure
Aug 12th • 10 mins read
02
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD
Outcome measures for oncology alternative payment models: practical considerations and recommendations
Dec 1st • 10 mins read
03
Kenji Omae, Yuki Kataoka, Yasushi Tsujimoto, Yusuke Tsutsumi, Yosuke Yamamoto, Shunichi Fukuhara, Toshi A Furukawa
Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation
Oct 24th • 18 mins read
04
Shani Paluch-Shimon, Nathan I. Cherny, Elisabeth G.E. de Vries, Urania Dafni, Martine J. Piccart, Nicola Jane Latino, Fatima Cardoso
Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
Sep 6th • 20 mins read
05
R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
Aug 2nd • 8 mins read
06
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Apr 29th • 8 mins read
Leon Rozen
Michael Pietrack
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology
In this episode of The Authority Company Podcast, host Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard, co-authors of Voices of Oncology and co-founders of the...
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
We are proud to announce the forthcoming publication of Voices of Oncology — a first-of-its-kind collection of expert perspectives from across the oncology ecosystem, arriving July 2025 in partnership with...
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
At the heart of the Oncology Voice Network (OVN) is a powerful mission: to unify oncology leaders across disciplines and accelerate the development of solutions that truly serve patients. Driving...